| Literature DB >> 33436314 |
Virginia Balouz1, Leonel Bracco2, Alejandro D Ricci2, Guadalupe Romer1, Fernán Agüero3, Carlos A Buscaglia4.
Abstract
Trypanosoma cruzi, the protozoan agent of Chagas' disease, displays a complex population structure made up of multiple strains showing a diverse ecoepidemiological distribution. Parasite genetic variability may be associated with disease outcome, hence stressing the need to develop methods for T. cruzi typing in vivo. Serological typing methods that exploit the presence of host antibodies raised against polymorphic parasite antigens emerge as an appealing approach to address this issue. These techniques are robust, simple, cost-effective, and are not curtailed by methodological/biological limitations intrinsic to available genotyping methods. Here, we critically assess the progress towards T. cruzi serotyping and discuss the opportunity provided by high-throughput immunomics to improve this field.Entities:
Keywords: Trypanosoma cruzi; discrete typing units; genetic variability; high-throughput immunomics; serotyping; trypomastigote small surface antigen
Mesh:
Year: 2021 PMID: 33436314 PMCID: PMC8900812 DOI: 10.1016/j.pt.2020.12.002
Source DB: PubMed Journal: Trends Parasitol ISSN: 1471-4922